NCT03294044

Brief Summary

This study verifies efficacy of Smart Health Management Program developed for patients with chronic illness. The aim of the study is to observe the changes in clinical indicators, quality of life and health related behaviors when providing self-management programs with ICT for chronic disease patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

October 27, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

October 24, 2018

Status Verified

October 1, 2018

Enrollment Period

5 months

First QC Date

September 19, 2017

Last Update Submit

October 22, 2018

Conditions

Keywords

Self-Management IT Program

Outcome Measures

Primary Outcomes (3)

  • Success in clinical outcomes of Hypertension from baseline to 3 months

    Change in Systolic blood pressure(mmHg)

    Baseline, 3 months post-intervention

  • Success in clinical outcomes of Dyslipidemia from baseline to 3 months

    Change in LDL Cholesterol (mg/dL)

    Baseline, 3 months post-intervention

  • Success in clinical outcomes of primary disease Diabetes from baseline to 3 months

    Change in HbA1c (%)

    Baseline, 3 months post-intervention

Secondary Outcomes (6)

  • Health behavior patterns

    Baseline, 3 months post-intervention

  • Depression

    Baseline, 3 months post-intervention

  • Health Management Strategies

    Baseline, 3 months post-intervention

  • Quality of life (SF-12)

    Baseline, 3 months post-intervention

  • Quality of life (Mcgill QOL)

    Baseline, 3 months post-intervention

  • +1 more secondary outcomes

Study Arms (2)

ICT programs

EXPERIMENTAL

ICT programs that include health information learning by disease, and self-management based on Smart Management Strategy for Health (SMASH) are provided. After that, subjects will conduct self-management health care for 12 weeks. After 3 months, they finish self-management ICT programs, and then they fill out the questionnaire.

Behavioral: ICT programs

A book about chronic disease

ACTIVE COMPARATOR

Subjects in the group get a book about chronic disease for patients. After 3 months, they finish reading the materials, they fill out the questionnaire.

Behavioral: A book about chronic disease

Interventions

ICT programsBEHAVIORAL

ICT programs that include health information learning by disease and self-management based on Smart Management Strategy for Health (SMASH).

ICT programs

A Take-home book about chronic disease are provided for self-education

A book about chronic disease

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject 19 years old and more
  • Subject who understands the purpose of the study and signs with informed consent form
  • Subject with chronic disease (hypertension, diabetes, dyslipidemia)
  • Subject with more than one Poor Disease Control Indicator
  • HbA1C 7.0% or more
  • Systolic BP 140mmHg or more
  • LDL-cholesterol 130mg/dL or more
  • Subjects who use smart phones and PCs (those who can use ICT-based health care programs)

You may not qualify if:

  • Inability to speak, understand, or write Korean
  • Inability to understand the contents of the provided materials due to poor eyesight and hearing
  • Medical conditions that would limit adherence to participation of the clinical trial (as confirmed by their referring physician; e.g. dyspnea, severe depression and other mental disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University

Seoul, South Korea

Location

Related Publications (1)

  • Yun YH, Kang E, Cho YM, Park SM, Kim YJ, Lee HY, Kim KH, Lee K, Koo HY, Kim S, Rhee Y, Lee J, Min JH, Sim JA. Efficacy of an Electronic Health Management Program for Patients With Cardiovascular Risk: Randomized Controlled Trial. J Med Internet Res. 2020 Jan 22;22(1):e15057. doi: 10.2196/15057.

MeSH Terms

Conditions

HypertensionDyslipidemiasDiabetes Mellitus

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism DisordersEndocrine System Diseases

Study Officials

  • Young Ho Yun, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 19, 2017

First Posted

September 26, 2017

Study Start

October 27, 2017

Primary Completion

March 26, 2018

Study Completion

July 31, 2018

Last Updated

October 24, 2018

Record last verified: 2018-10

Locations